Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000664813 | SCV000788828 | likely pathogenic | Peroxisome biogenesis disorder type 3B; Peroxisome biogenesis disorder 3A (Zellweger) | 2017-01-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001387645 | SCV001588317 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2023-09-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu75Valfs*2) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 550148). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001387645 | SCV004201445 | likely pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2023-11-30 | criteria provided, single submitter | clinical testing |